Manufacturer
Celgene
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 27
- Molecules
- 10
- Therapy areas
- 3
Celgene is a pharmaceutical manufacturer based in United States. MedsAcross lists 27 of its products across 10 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Celgene Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Celgene products through licensed channels, with the documents your regulator needs.
Immunology and transplant
17 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Pomalyst 1 mg capsuleOral | Pomalidomide | US FDA | Available on request |
| Pomalyst 2 mg capsuleOral | Pomalidomide | US FDA | Available on request |
| Pomalyst 3 mg capsuleOral | Pomalidomide | US FDA | Available on request |
| Pomalyst 4 mg capsuleOral | Pomalidomide | US FDA | Available on request |
| Revlimid 10 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Revlimid 15 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Revlimid 2.5 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Revlimid 20 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Revlimid 25 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Revlimid 5 mg capsuleOral | Lenalidomide | US FDA | Available on request |
| Thalomid 100 mg capsuleOral | Thalidomide | US FDA | Available on request |
| Thalomid 150 mg capsuleOral | Thalidomide | US FDA | Available on request |
| Thalomid 200 mg capsuleOral | Thalidomide | US FDA | Available on request |
| Thalomid 50 mg capsuleOral | Thalidomide | US FDA | Available on request |
| Zeposia 0.92 mg capsuleOral | Ozanimod | US FDA | Available on request |
| ZEPOSIA 7-Day Starter Pack kit | Ozanimod | US FDA | Available on request |
| ZEPOSIA Starter Kit kit | Ozanimod | US FDA | Available on request |
Oncology
8 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Abecma 300000000 injectable suspensionIntravenous Cold chain | Idecabtagene vicleucel | US FDA | Available on request |
| Idhifa 100 mg tabletOral | Enasidenib | US FDA | Available on request |
| Idhifa 50 mg tabletOral | Enasidenib | US FDA | Available on request |
| Inrebic 100 mg capsuleOral | Fedratinib | US FDA | Available on request |
| Istodax kit | Romidepsin | US FDA | Available on request |
| Onureg 200 mg tabletOral | Azacitidine | US FDA | Available on request |
| Onureg 300 mg tabletOral | Azacitidine | US FDA | Available on request |
| Vidaza 100 mg powder for injectionIntravenous, subcutaneous | Azacitidine | US FDA | Available on request |
Haematology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Reblozyl 25 mg powder for injectionSubcutaneous Cold chain | Luspatercept | US FDA | Available on request |
| Reblozyl 75 mg powder for injectionSubcutaneous Cold chain | Luspatercept | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Celgene
Send a request for any of these products. We confirm the licensed source, documents and lead time.